Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act-Reference-Cited by-同舟云学术

Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act

Published:2023-03-01 Issue:3 Volume:80 Page:278
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Geissler Kimberley H.¹,Ericson Keith M.²³,Simon Gregory E.⁴,Qian Jing¹,Zeber John E.¹

Affiliation:

1. University of Massachusetts Amherst School of Public Health and Health Sciences, Amherst

2. National Bureau for Economic Research, Cambridge, Massachusetts

3. Boston University Questrom School of Business, Boston, Massachusetts

4. Kaiser Permanente Washington Health Research Institute, Seattle, Washington

Abstract

This cross-sectional study uses Medical Expenditure Panel Survey data to assess differences in insurance coverage for individuals with schizophrenia before vs after implementation of the Patient Protection and Affordable Care Act (ACA).

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2800173/jamapsychiatry_geissler_2023_ld_220011_1677529736.19554.pdf

Reference6 articles.

1. Health insurance coverage among persons with schizophrenia in the United States.;Khaykin;Psychiatr Serv,2010

2. Real-world analysis of insurance churn among young adults with schizophrenia using the Colorado All-Payer Claims Database.;Pesa;J Manag Care Spec Pharm,2022

3. Will health insurance reform in the United States help people with schizophrenia?;Goldman;Schizophr Bull,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and hospitalizations following rejection, reversal, or payment of the initial once-monthly paliperidone palmitate long-acting injectable antipsychotic claim among patients with schizophrenia or schizoaffective disorder;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Who Gets Mental Health Care?—The Role of Burden and Cash-Paying Markets;JAMA Health Forum;2024-03-22

3. Transitions in health insurance among continuously insured patients with schizophrenia;Schizophrenia;2024-02-26

4. Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia;Patient Preference and Adherence;2024-01

5. One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication;Administration and Policy in Mental Health and Mental Health Services Research;2023-12-10